The GLP-1 agonists like tirzepatide are genuinely revolutionary for fat loss and metabolic health
The combination hypothesis is that addressing both vascular/mucosal protection (BPC-157 territory) and cellular motility required for tissue remodeling (TB-500 territory) may produce better outcomes than either alone, though this needs study-specific verification
Summary Keywords Parkinsons disease, metabolic sybdrome, diabetes, Obesity, GLP-1/GIP RA Citation Invernizzi F, Ciocca L, Contaldi E, Inverso D, Calandrella D, Mignone F, Barichella M, Isaias IU and Pezzoli G (2025) Metabolic Parkinsons disease
"GHK influenced the expression of about 4,000 human genes, shifting their expression from a diseased or aged state toward a healthier profile." Pickart L., Vasquez-Soltero J.M., Margolina A
But the human dermatology evidence is predominantly topical, and, as set out above, even there it remains modest and partly subjective
They are particularly beneficial for vegetarians and vegans (since B12 is found primarily in animal products), older adults with reduced absorption capacity, individuals with digestive conditions such as Crohn's disease or celiac disease, and anyone who has had gastric bypass surgery